Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Book Value per Share : $2.41 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Book Value per Share?

Shanghai Fosun Pharmaceutical (Group) Co's book value per share for the quarter that ended in Mar. 2024 was $2.41.

During the past 12 months, Shanghai Fosun Pharmaceutical (Group) Co's average Book Value Per Share Growth Rate was 2.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 5.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 9.50% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Shanghai Fosun Pharmaceutical (Group) Co was 117.10% per year. The lowest was 5.80% per year. And the median was 13.65% per year.

Shanghai Fosun Pharmaceutical (Group) Co's current price is $1.57. Its book value per share for the quarter that ended in Mar. 2024 was $2.41. Hence, today's PB Ratio of Shanghai Fosun Pharmaceutical (Group) Co is 0.65.

During the past 13 years, the highest P/B Ratio of Shanghai Fosun Pharmaceutical (Group) Co was 5.54. The lowest was 1.26. And the median was 2.81.

Good Sign:

Shanghai Fosun Pharmaceutical (Group) Co Ltd stock PB Ratio (=1.36) is close to 10-year low of 1.26

Shanghai Fosun Pharmaceutical (Group) Co Book Value per Share Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Book Value per Share Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Book Value per Share

Get a 7-Day Free Trial

1.77

2.21

2.40

2.39

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Book Value per Share	Get a 7-Day Free Trial															2.47	2.38	2.35	2.39	2.41

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai Fosun Pharmaceutical (Group) Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's PB Ratio falls into.

Shanghai Fosun Pharmaceutical (Group) Co Book Value per Share Calculation

Shanghai Fosun Pharmaceutical (Group) Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6,398	-	0)	/	2,672
	=	2.39

Shanghai Fosun Pharmaceutical (Group) Co's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(6,436	-	0)	/	2,672
	=	2.41

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Shanghai Fosun Pharmaceutical (Group) Co (OTCPK:SFOSF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Shanghai Fosun Pharmaceutical (Group) Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fosun Pharmaceutical (Group) Co (Shanghai Fosun Pharmaceutical (Group) Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (OTCPK:SFOSF) » Definitions » Book Value per Share

Traded in Other Exchanges

02196:Hong Kong 08HH:Germany 08HH:Germany 600196:China

Address

No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233

Website

https://www.fosunpharma.com

Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.